Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Amyotrophic Lateral Sclerosis
NCT03766321Completed
- Sponsor
- Azienda Ospedaliera Universitaria Policlinico
- Start
- Jul 2020
- Primary completion
- Feb 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial in amyotrophic lateral sclerosis (ALS) comparing Fecal microbiota transplantation (FMT) with Placebo (2 arms). Primary endpoint: Change in Tregs number at 6 months. Started Jul 2020; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT03766321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03766321.